Decreased TET2 gene expression during chronic myeloid leukemia progression

Leukemia Research
|July 29, 2011
PubMed
Summary

Ten-eleven-translocation-2 (TET2) gene alterations are key in myeloid cancers. This study found a TET2 deletion, not a mutation, causing reduced gene expression in chronic myeloid leukemia progression.